A team of researchers report that a commercial test designed to rule out the presence of genetic biomarkers of prostate cancer may be accurate enough to exclude the need for repeat prostate biopsies in many men. "Often, one biopsy is not enough to definitively rule out prostate cancer," says study researcher Jonathan Epstein, M.D., director of the Division of Surgical Pathology and a professor of pathology, urology and oncology at the Johns Hopkins University School ...
Read More
You have just read an article categorized health
titled Scientists Affirm Value of Epigenetic Test for Markers of Prostate Cancer.
Written by:
editor -
Sunday, June 1, 2014
There are currently no comments for "Scientists Affirm Value of Epigenetic Test for Markers of Prostate Cancer"
Post a Comment